NT-proBNP
WordNet
- relating to or occurring in a term or fixed period of time; "terminal examinations"; "terminal payments"
- a contact on an electrical device (such as a battery) at which electric current enters or leaves (同)pole
- station where transport vehicles load or unload passengers or goods (同)terminus, depot
- electronic equipment consisting of a device providing access to a computer; has a keyboard and display
- being or situated at an end; "the endmost pillar"; "terminal buds on a branch"; "a terminal station"; "the terminal syllable"
- causing or ending in or approaching death; "a terminal patient"; "terminal cancer"
- of or relating to or situated at the ends of a delivery route; "freight pickup is a terminal service"; "terminal charges"
- the 2nd letter of the Roman alphabet (同)b
- the blood group whose red cells carry the B antigen (同)type_B, group B
- the 14th letter of the Roman alphabet (同)n
PrepTutorEJDIC
- 『終りの』,末端の / 毎期の,定期の;学期末の / 『死に至る』, / 末端 / (電池の)端子 / (町の中心に近い)空港バス発着場;(一般に,鉄道・バスの)終点,終着駅
- nitrogenの化学記号
- neodymiumの化学記号
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Left ventricular dysfunction screening in hypertensive patients with N-terminal pro-B-type natriuretic peptide and electrocardiogram.
- Limkakeng AT Jr, Drake W, Mani G, Freeman D, Best R, Newby LK, Chandra A.SourceDepartment of Surgery, Division of Emergency Medicine, Duke University Medical Center, Durham, NC 27710, USA.
- The American journal of emergency medicine.Am J Emerg Med.2012 Jan;30(1):214-7. Epub 2010 Dec 24.
- OBJECTIVE: Early recognition of left ventricular hypertrophy is important because antihypertensive treatment decreases morbidity and mortality. The ideal screening method for left ventricular hypertrophy in hypertensive emergency department (ED) patients has not been identified. Our objective was to
- PMID 21185671
- Usefulness of serial N-terminal pro-B-type natriuretic Peptide measurements for determining prognosis in patients with pulmonary arterial hypertension.
- Mauritz GJ, Rizopoulos D, Groepenhoff H, Tiede H, Felix J, Eilers P, Bosboom J, Postmus PE, Westerhof N, Vonk-Noordegraaf A.SourceDepartment of Pulmonary Diseases, Institute for Cardiovascular Research and VU University Medical Center, Amsterdam, The Netherlands.
- The American journal of cardiology.Am J Cardiol.2011 Dec 1;108(11):1645-50. Epub 2011 Sep 3.
- Previous studies have shown the prognostic benefit of N-terminal pro-brain natriuretic peptide (NT-pro-BNP) in pulmonary arterial hypertension (PAH) at time of diagnosis. However, there are only limited data on the clinical utility of serial measurements of the inactive peptide NT-pro-BNP in PAH. Th
- PMID 21890089
Japanese Journal
- 臨床研究・症例報告 NT-pro BNPによる急性期川崎病の診断および尿中β2-MGによるIVIG不応例予測の有用性
- N-terminal pro-BNP is a novel biomarker for integrated cardio-renal burden and early risk stratification in patients admitted for cardiac emergency
- YAMASHITA Teruyo,SEINO Yoshihiko,OGAWA Akio,OGATA Ken-ichi,FUKUSHIMA Masato,TANAKA Keiji,MIZUNO Kyoichi
- Journal of cardiology 55(3), 377-383, 2010-05-15
- NAID 10027052747
Related Links
- But now researchers say that analyzing levels of a fragment of this hormone known as the N-terminal fragment (N-BNP) can more accurately predict long-term risks in patients with heart attack or chest pain (angina) than looking at BNP alone. ...
★リンクテーブル★
[★]
- 同
- N-terminal BNP, N-terminal pro-BNP NT proBNP
単位
心疾患のマーカー
- 参考1
|
心不全の可能性は きわめて低い
|
心不全の可能性は 低いが、可能ならば 経過観察
|
軽度の心不全の 可能性があるので 精査、経過観察
|
治療対象となる 心不全の可能性有り 精査 or 専門医紹介
|
治療対象となる 心不全の可能性高 精査 or 専門医紹介
|
BNP
|
0~18.4
|
18.4~40
|
40~100
|
100~200
|
200~
|
NT-proBNP
|
0~125
|
125~400
|
400~900
|
900~
|
参考
- http://www.asas.or.jp/jhfs/topics/bnp201300403.html
- http://eccm.tokyo-med.ac.jp/report/hachioji/study_6.html
[★]
- Mg2+存在下でC3, B, Dが反応してC3bBbとなり、これがC3転換酵素(C3bBb)あるいはC5転換酵素(C3bBb3b)を形成する。これらはP(properdin)と結合して活性化し、それぞれC3、C5を活性化する
[★]
- 関
- distal、end、end stage、ending、extremity、full-blown、terminal region、terminal stage、terminally、termini、terminus
[★]
- 関
- number of experiment、sample size
- pの前の[n]はmと記載する。synptom→symptom
[★]
[★]
脳性ナトリウム利尿ペプチド B-type natriuretic peptide